ESH Video

5th TRANSLATIONAL RESEARCH CONFERENCE MULTIPLE MYELOMA: GOING VIRTUAL!

July 16, 2020

5th TRANSLATIONAL RESEARCH CONFERENCE
MULTIPLE MYELOMA

October 8-11, 2020

MOVING ONLINE!

Chairs: Kenneth C. Anderson, Maria-Victoria Mateos, Philippe Moreau

DEADLINE FOR ABSTRACTS:
JULY 22, 2020





You are invited to submit a Biology, a Clinical or a Trials in Progress abstracts for presentation as a brief oral communication or a E-Poster during the E-Conference.


ABOUT THE E-CONFERENCE:

In view of continuing COVID-19 related challenges and uncertainties, ESH has decided to hold this year’s Translational Research Conference on Multiple Myeloma as a virtual event. Please note that it will begin one day earlier than initially planned, extending from October 8-11, 2020.

An outstanding faculty of distinguished global experts will present the most recent advances and new perspectives in the field of Multiple Myeloma and plasma disorders, from pathophysiology to diagnosis and therapy, including current challenges and new perspectives.
The plenary E-Conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for scientific discussion and interaction.
Registered participants will further benefit from opportunities for informal scientific interaction with the world’s leading experts in the field during closed Meet the Expert sessions and E-Mentored Posters Walks.

Participants will be joining us from all over the world and from different time zones. To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both the LIVE PROGRAMME  and the PROGRAMME ON DEMAND.
 
MAIN TOPICS:
- Smoldering Myeloma
- Diagnosis of Multiple Myeloma
- Frontline therapy in patients not eligible for autologous Stem Cell transplantation
- Frontline therapy in patients eligible for autologous Stem Cell transplantation
- MRD and the microenvironment
- Relapsed Multiple Myeloma
- The future: recent clinical trials in relapse
- Data management issues
- Plasma Cell disorders

MORE INFORMATION

UPDATED PROGRAMME

MEET THE FACULTY

STAY TUNED!
REGISTRATION TO THE E-CONFERENCE
WILL OPEN SOON



 

With the support of*:


Premium E-Conference Partner
**********



Diamond E-Conference Partner
**********

 

Ruby E-Conference Partners
**********



*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.